MRI-CT融合成像评估肝脏恶性肿瘤冷冻消融边缘
回顾性分析35例患者47个肝脏肿瘤,采用CT引导冷冻消融,利用术前MRI与术中CT融合成像评估最小消融边缘(MAM)。融合成像成功率为97.9%(46/47),MAM<0 mm组局部肿瘤进展(LTP)发生率为83.3%(15/18),MAM 0-5 mm组为64%(16/25),两组累积LTP率差异有统计学意义(p=0.012)。结论认为融合成像可行且有助于评估MAM。
要点
- MRI-CT融合成像评估冷冻消融MAM成功率达97.9%(46/47)。
- MAM<0 mm组LTP发生率83.3%(15/18),高于MAM 0-5 mm组的64%(16/25)。
- 31例LTP中24例(77.4%)位于肝包膜下区域。
核心结论
- 术前MRI与术中CT融合成像可行,有助于评估肝脏恶性肿瘤冷冻消融的最小消融边缘。
研究设计与样本
- 回顾性研究,纳入35例患者共47个肝脏肿瘤,均接受CT引导冷冻消融;在工作站上融合术前MRI与术中CT数据;参考标准为随访期间评估的局部肿瘤进展(LTP)。
关键影像表现/征象
- 融合成像上MAM分为三组:I组MAM<0 mm(肿瘤突出消融区),II组MAM 0-5 mm,III组MAM≥5 mm。
- 47个肿瘤中融合成像成功46个(97.9%)。
- 46个可评估肿瘤中MAM分组为I组18个、II组25个、III组3个。
- 31例LTP中24例(77.4%)发生于肝脏包膜下区域。
诊断标准与关键数值
- MAM<0 mm定义为肿瘤突出消融区(I组),MAM 0-5 mm为II组,MAM≥5 mm为III组。
- I组18个病灶中15个(83.3%)出现LTP;II组25个病灶中16个(64%)出现LTP。
- II组累积LTP率显著低于I组(p=0.012)。
临床应用与阅片要点
- 可利用术前MRI与术中CT融合成像评估冷冻消融的最小消融边缘。
- MAM<0 mm(肿瘤突出消融区)与较高的LTP发生率相关(83.3% vs 64%,p=0.012)。
- 肝包膜下区域是LTP常见部位(31例中24例,77.4%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To demonstrate the feasibility of magnetic resonance imaging (MRI)-computed tomography (CT) fusion imaging for the assessment of the ablative margin after cryoablation in hepatic malignancies.
MATERIALS AND METHODS: This retrospective study analysed 35 patients with 47 liver tumours treated with CT-guided cryoablation. Fusion images of pre-ablation MRI and intraoperative CT data were created on a workstation. Minimal ablative margin (MAM) assessment was categorised into three groups: (I) MAM <0 mm (tumour protruded through the ablation zone), (II) MAM 0-5 mm, and (III) MAM ≥5 mm. Local tumour progression (LTP) was assessed during follow-up.
RESULTS: MRI-CT fusion imaging was successfully achieved in 46 (97.9%) of 47 lesions. LTP was detected in 67.4% (31/46) of cases. Twenty-four (77.4%) of 31 LTPs occurred in the subcapsular region of the liver. Using fusion images, the MAM was classified as groups I, II, and III in 18, 25, and three tumours, respectively. In group I, LTP was found in 15 (83.3%) of 18 lesions, whereas in group II, LTP was detected in 16 (64%) of 25 lesions. The cumulative LTP rate in group II was significantly lower than that in group I (p=0.012).
CONCLUSION: Pre-ablation MRI and intraoperative CT fusion imaging is feasible and useful for evaluating the MAM of cryoablation in hepatic malignancies.
引用
- Chen C, Xu LC, Wang Y, et al. Assessment of the cryoablation margin using MRI-CT fusion imaging in hepatic malignancies. Clin Radiol. 2019. PMID: 31076083. doi:10.1016/j.crad.2019.03.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。